Share to: share facebook share twitter share wa share telegram print page

Actinic granuloma

Actinic granuloma
Other namesO'Brien granuloma
SpecialtyDermatology Edit this on Wikidata
CausesInflammatory response to sun damage and possibly to injured elastic fibers.[1]
Diagnostic methodSkin biopsy.[1]
Differential diagnosisGranuloma annulare and necrobiosis lipoidica.[1]
PreventionSun protection.[1]

Actinic granuloma (AG) was first described by O'Brien in 1975 as a rare granulomatous disease.[2] Lesions appear on sun-exposed areas, usually on the face, neck, and scalp, with a slight preference for middle-aged women. They are typically asymptomatic, single or multiple, annular or polycyclic lesions measuring up to 6 cm in diameter, with slow centrifugal expansion, an erythematous elevated edge, and a hypopigmented, atrophic center.[3]

The granulomatous inflammation is thought to be caused by a cell-mediated autoimmune response against damaged elastic fibers. When actinic granuloma-like lesions appear in non-exposed areas, the rash is known as annular elastolytic giant cell granuloma. Though these can be easily distinguished based on histopathologic features and laboratory findings, the differential diagnosis includes tinea corporis, sarcoidosis, subacute lupus erythematosus, granuloma annulare, and other infectious granulomatous diseases. Chloroquine, intralesional or systemic steroids, cyclosporine, isotretinoin, acitretin, and laser treatment have all been tried with varying degrees of success.[4]

Signs and symptoms

The lesions, which primarily affect sun-exposed areas such as the face, neck, chest, and upper arms, begin as red or skin-colored papules and progress insidiously to annular plaques with uplifted edges and atrophic central skin.[5] Actinic granulomais has been reported to have a slow but self-limited course that can last up to ten years.[3]

Causes

Solar-damaged elastic fibers are thought to be the initial cause of this disease, acting as an antigenic trigger for a CD4+ T-helper cell-mediated granulomatous immune response.[5] It has also been linked to long-term doxycycline use.[6]

Diagnosis

Actinic granuloma is distinguished histopathologically by multinucleated foreign body giant cells that phagocytize the degenerated elastic fibers, a process known as elastophagocytosis. At the solar elastosis level, there is no necrobiosis, such as facial necrobiosis lipoidica, or mucinosis, such as GA or sarcoid-like granuloma in the dermis.[7]

Because of the similarities in clinical manifestations, Actinic granuloma is easily confused with annular granuloma and sarcoidosis. In such cases, a histopathological examination is required. Annular granuloma is characterized by papules that coalesce into annular plaques and preferentially affect the extensor aspects of the extremities. Sarcoidosis lesions, on the other hand, are typically symmetrically distributed on the face, neck, upper trunk, and extremities, particularly within preexisting scars or near sites of prior trauma. Clinically, it appears as red to red-brown papules and plaques that are sometimes violaceous or annular. Sarcoidosis is distinguished histologically by the appearance of superficial and deep dermal epithelioid cell granulomas without prominent lymphocyte or plasma cell infiltrates.[5]

Treatment

Actinic granuloma does not have a specific treatment. Some patients experience spontaneous remission of skin lesions. For widespread AG, systemic glucocorticoids, hydroxychloroquine, and niacinamide are effective, and topical glucocorticoids or retinoids can be used.[5] Actinic granuloma has also been successfully treated with pulsed-dye laser therapy and fractionated carbon dioxide laser therapy.[8]

See also

References

  1. ^ a b c d "Actinic granuloma". DermNet. Retrieved November 16, 2023.
  2. ^ O'Brien, John P. (April 1, 1975). "Actinic Granuloma". Archives of Dermatology. 111 (4): 460–466. doi:10.1001/archderm.1975.01630160050003. ISSN 0003-987X. PMID 1122146. Retrieved November 15, 2023.
  3. ^ a b Coutinho, InêsD; Ramos, LeonorI C; Brites, MariaM; Tellechea, Oscar (2015). "O′Brien actinic granuloma: A case report and brief review of literature". Indian Journal of Dermatology. 60 (4): 391–393. doi:10.4103/0019-5154.160493. ISSN 0019-5154. PMC 4533541. PMID 26288411.
  4. ^ Liu, Wei; Ma, Dong-Lai (August 12, 2019). "Actinic granuloma". Canadian Medical Association Journal. 191 (32): 895. doi:10.1503/cmaj.190120. ISSN 0820-3946. PMC 6690822. PMID 31405837.
  5. ^ a b c d Hao, Zhi-Min; Xiong, Jing-Shu; Xu, Xiu-Lian; Gu, Heng; Chen, Min (October 9, 2019). "Actinic Granuloma: A Case Report". International Journal of Dermatology and Venereology. 2 (4): 244–246. doi:10.1097/jd9.0000000000000048. ISSN 2096-5540. Retrieved November 15, 2023.
  6. ^ Lim, Davin S; Triscott, Joe (2003). "O'Brien's actinic granuloma in association with prolonged doxycycline phototoxicity". Australasian Journal of Dermatology. 44 (1): 67–70. doi:10.1046/j.1440-0960.2003.00641.x. ISSN 0004-8380. PMID 12581086. S2CID 22499868. Retrieved November 15, 2023.
  7. ^ Yaghoobi, Reza; Ranjbari, Nastaran; Feily, Amir (July 31, 2014). "Actinic granuloma". Dermatology Practical & Conceptual. 4 (3): 31–32. doi:10.5826/dpc.0403a04. ISSN 2160-9381. PMC 4131994. PMID 25126454.
  8. ^ Mamalis, Andrew; Ho, Derek; Parsi, Kory K.; Jagdeo, Jared (2018). "Successful Treatment of Actinic Granuloma With Pulsed-Dye Laser and Fractionated Carbon Dioxide Laser". Dermatologic Surgery. 44 (3): 452–454. doi:10.1097/dss.0000000000001227. ISSN 1076-0512. PMID 28746256. S2CID 3714885. Retrieved November 15, 2023.
Kembali kehalaman sebelumnya